Hepatic phenotype of liver fatty acid binding protein gene-ablated mice

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 297, Issue 6, 2009, Pages

  Martin, Gregory G ^a   Atshaves, Barbara P ^a   Huang, Huan ^a   McIntosh, Avery L ^a   Williams, Brad J ^b   Pai, Pei Jing ^b   Russell, David H ^b   Kier, Ann B ^b   Schroeder, Friedhelm ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Gene ablation; Mouse; Triacylglycerol

Indexed keywords

CHOLESTEROL; DANSYLCHOLESTEROL; FATTY ACID BINDING PROTEIN; FREE CHOLESTEROL BENZOPHENONE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; C57BL 6 MOUSE; CHOLESTEROL LIVER LEVEL; CIRCULAR DICHROISM; CONTROLLED STUDY; CROSS LINKING; FATTY ACID METABOLISM; FEMALE; GENE; ISOTHERMAL TITRATION CALORIMETRY; LIVER METABOLISM; MALE; MOUSE; NONHUMAN; PHENOTYPE; PHOTOACTIVATION; PRIORITY JOURNAL; PROTEIN BINDING; REGULATORY MECHANISM; TRIACYLGLYCEROL BLOOD LEVEL;

4-CHLORO-7-NITROBENZOFURAZAN; ANIMALS; BINDING SITES; BINDING, COMPETITIVE; CALORIMETRY; CARRIER PROTEINS; CHOLESTEROL; CHOLESTEROL ESTERS; CIRCULAR DICHROISM; CROSSES, GENETIC; FATTY ACID-BINDING PROTEINS; FATTY ACIDS; FEMALE; GENOTYPE; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHENOTYPE; PHOSPHOLIPIDS; PROTEIN CONFORMATION; SEX FACTORS; SPECTROMETRY, FLUORESCENCE; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TRIGLYCERIDES;

EID: 72749092398     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00116.2009     Document Type: Article

References (104)

1. Amigo L, Zanlungo S, Miquel JF, Glick JM, Hyogo H, Cohen DE, Rigotti A, Nervi F. Hepatic overexpression of sterol carrier protein-2 inhibits VLDL production and reciprocally enhances biliary lipid secretion. J Lipid Res 44: 399-407, 2003. (Pubitemid 37287783)
2. Atshaves BP, McIntosh AL, Landrock D, Payne HR, Mackie J, Maeda N, Ball JM, Schroeder F, Kier AB. Effect of SCP-x gene ablation on branched-chain fatty acid metabolism. Am J Physiol Gastrointest Liver Physiol 292: G939-G951, 2007.
3. Atshaves BP, McIntosh AL, Lyuksyutova OI, Zipfel WR, Webb WW, Schroeder F. Liver fatty acid binding protein gene ablation inhibits branched-chain fatty acid metabolism in cultured primary hepatocytes. J Biol Chem 279: 30954-30965, 2004.
4. Atshaves BP, McIntosh AL, Payne HR, Mackie J, Kier AB, Schroeder F. Effect of branched-chain fatty acid on lipid dynamics in mice lacking liver fatty acid binding protein gene. Am J Physiol Cell Physiol 288: C543-C558, 2005.
5. Atshaves BP, Payne HR, McIntosh AL, Tichy SE, Russell D, Kier AB, Schroeder F. Sexually dimorphic metabolism of branched chain lipids in C57BL/6J mice. J Lipid Res 45: 812-830, 2004. (Pubitemid 38552851)
6. Atshaves BP, Petrescu A, Starodub O, Roths J, Kier AB, Schroeder F. Expression and intracellular processing of the 58 kDa sterol carrier protein 2/3-oxoacyl-CoA thiolase in transfected mouse L-cell fibroblasts. J Lipid Res 40: 610-622, 1999.
7. Atshaves BP, Storey S, Huang H, Schroeder F. Liver fatty acid binding protein expression enhances branched-chain fatty acid metabolism. Mol Cell Biochem 259: 115-129, 2004. (Pubitemid 38519223)
8. Atshaves BP, Storey SM, Petrescu AD, Greenberg CC, Lyuksyutova OI, Smith R, Schroeder F. Expression of fatty acid binding proteins inhibits lipid accumulation and alters toxicity in L-cell fibroblasts. Am J Physiol Cell Physiol 283: C688-C703, 2002.
9. Avdulov NA, Chochina SV, Igbavboa U, Warden CH, Schroeder F, Wood WG. Lipid binding to sterol carrier protein-2 is inhibited by ethanol. Biochim Biophys Acta 1437: 37-45, 1999. (Pubitemid 29242901)
10. Baens M, Noels H, Broeckx V, Hagens S, Fevery S, Billiau AD, Vankelecom H, Marynen P. The dark side of EGFP: defective polyubiquitination. PLoS ONE 1: e54, 2006.
11. Bogdanov AM, Mishin AS, Yampolsky IV, Belousov VV, Chudakov DM, Subach FV, Verkhusha VV, Lukyanov S, Lukyonov KA. Green fluorescent proteins are light-induced electron donors. Nat Chem Biol 5: 459-461, 2009.
12. Borboni P, Magnaterra R, Porzio O, Fusco A, Sesti G, Bertoli A, Lauro R, Marlier L. DBI mRNA is expressed in endocrine pancreas and its post-translational product DBI33-50 inhibits insulin release. Endocrine 3: 267-271, 1995.
13. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72: 248-254, 1976.
14. Brouillette C, Bossé Y, Pérusse L, Gaudet D, Vohl MC. Effect of liver fatty acid binding protein (FABP) T94A missense mutation on plasma lipoprotein responsiveness to treatment with fenofibrate. J Hum Genet 49: 424-432, 2004.
15. Chao H, Zhou M, McIntosh A, Schroeder F, Kier AB. Acyl CoA binding protein and cholesterol differentially alter fatty acyl CoA utilization by microsomal acyl CoA: cholesterol transferase. J Lipid Res 44: 72-83, 2003.
16. Costa E, Guidotti A. Diazepam binding inhibitor (DBI): a peptide with multiple biological actions. Life Sci 49: 325-344, 1991.
17. Davies JK, Thumser AEA, Wilton DA. Binding of recombinant rat liver fatty acid binding protein to small anionic phospholipid vesicles results in ligand release: a model for interfacial binding and fatty acid targeting. Biochemistry 38: 16932-16940, 1999. (Pubitemid 30013700)
18. De Marinis E, Martini C, Trentalance A, Pallottini V. Sex differences in hepatic regulation of cholesterol homeostasis. J Endocrinol 198: 635-643, 2008.
19. De Stefanis P, Impagnatiello F, Berkovich A, Guidotti A. Inhibitory effect of ODN, a naturally occurring processing product of diazepam binding inhibitor, on secretagogues-induced insulin secretion. Regul Pept 56: 153-165, 1995.
20. Devgan V, Rao MRS, Seshagiri PB. Impact of embryonic expression of enhanced green fluorescent protein on early mouse development. Biochem Biophys Res Commun 313: 1030-1036, 2004. (Pubitemid 38050096)
21. Djouadi F, Weinheimer CJ, Saffitz JE, Pitchford C, Bastin J, Gonzalez FJ. A gender-related defect in lipid metabolism and glucose homeostasis in PPARalpha deficient mice. J Clin Invest 102: 1083-1091, 1998.
22. Dyson HJ, Rance M, Houghten RA, Wright PE, Lerner RA. Folding of immunogenic peptide fragments of proteins in water solution. II. The nascent helix. J Mol Biol 201: 201-217, 1988.
23. Engels W, van Bilsen M, Wolffenbuttel BHR, Van der Vusse GJ, Glatz JF. Cytochrome P450, peroxisome proliferation, and cytoplasmic fatty acid binding protein content in liver, heart, and kidney of the diabetic rat. Mol Cell Biochem 192: 53-61, 1999.
24. Erol E, Kumar LS, Cline GW, Shulman GI, Kelly DP, Binas B. Liver fatty acid-binding protein is required for high rates of hepatic fatty acid oxidation but not for the action of PPAR-α in fasting mice. FASEB J 18: 347-349, 2004.
25. Fex M, Lucas S, Winzell MS, Ahren B, Holm C, Mulder H. β-Cell lipases and insulin secretion. Diabetes 55: S24-S31, 2006.
26. Fielding PE, Russel JS, Spencer TA, Hakamata H, Nagao K, Fielding CJ. Sterol efflux to apolipoprotein A-1 originates from caveolin-rich microdomains and potentiates PDGF-dependent protein kinase activity. Biochemistry 41: 4929-4937, 2002.
27. Fischer RT, Cowlen MS, Dempsey ME, Schroeder F. Fluorescence of delta 5,7,9(11),22-ergostatetraen-3 beta-ol in micelles, sterol carrier protein complexes, and plasma membranes. Biochemistry 24: 3322-3331, 1985. (Pubitemid 15028734)
28. Fisher E, Weikert C, Klapper M, Lindner I, Mohlig M, Spranger J, Boeing H, Schrezenmeir J, Doring F. L-FABP T94A is associated with fasting triglycerides and LDL-cholesterol in women. Mol Genet Metab 91: 278-284, 2007.
29. Frolov A, Cho TH, Murphy EJ, Schroeder F. Isoforms of rat liver fatty acid binding protein differ in structure and affinity for fatty acids and fatty acyl CoAs. Biochemistry 36: 6545-6555, 1997.
30. Frolov A, Petrescu A, Atshaves BP, So PTC, Gratton E, Serrero G, Schroeder F. High density lipoprotein mediated cholesterol uptake and targeting to lipid droplets in intact L-cell fibroblasts. J Biol Chem 275: 12769-12780, 2000.
31. Frolov A, Woodford JK, Murphy EJ, Billheimer JT, Schroeder F. Spontaneous and protein-mediated sterol transfer between intracellular membranes. J Biol Chem 271: 16075-16083, 1996.
32. Frolov AA, Woodford JK, Murphy EJ, Billheimer JT, Schroeder F. Fibroblast membrane sterol kinetic domains: modulation by sterol carrier protein 2 and liver fatty acid binding protein. J Lipid Res 37: 1862-1874, 1996.
33. Fuchs M, Hafer A, Muench C, Kannenberg F, Teichmann S, Scheibner J, Stange EF, Seedorf U. Disruption of the sterol carrier protein 2 gene in mice impairs biliary lipid and hepatic cholesterol metabolism. J Biol Chem 276: 48058-48065, 2001. (Pubitemid 37370707)
34. Gallegos AM, Atshaves BP, Storey SM, Starodub O, Petrescu AD, Huang H, McIntosh A, Martin G, Chao H, Kier AB, Schroeder F. Gene structure, intracellular localization, and functional roles of sterol carrier protein-2. Prog Lipid Res 40: 498-563, 2001.
35. Gillilan RE, Ayers SD, Noy N. Structural basis for activation of fatty acid binding protein 4. J Mol Biol 372: 1246-1260, 2007. (Pubitemid 47374720)
36. Hostetler HA, Kier AB, Schroeder F. Very-long-chain and branchedchain fatty acyl CoAs are high-affinity ligands for the peroxisome proliferator-activated receptor alpha (PPARalpha). Biochemistry 45: 7669-7681, 2006.
37. Hostetler HA, McIntosh AL, Atshaves BP, Storey SM, Payne HR, Kier AB, Schroeder F. L-FABP interacts with PPARα in cultured primary hepatocytes. J Lipid Res 50: 1663-1675, 2009.
38. Hostetler HA, Petrescu AD, Kier AB, Schroeder F. Peroxisome proliferator activated receptor alpha (PPARalpha) interacts with high-affinity and is conformationally responsive to endogenous ligands. J Biol Chem 280: 18667-18682, 2005.
39. Huang H, Ball JA, Billheimer JT, Schroeder F. Interaction of the N-terminus of sterol carrier protein-2 with membranes: role of membrane curvature. Biochem J 344: 593-603, 1999. (Pubitemid 30011619)
40. Huang H, Ball JA, Billheimer JT, Schroeder F. The sterol carrier protein-2 amino terminus: a membrane interaction domain. Biochemistry 38: 13231-13243, 1999. (Pubitemid 129515646)
41. Huang H, Gallegos A, Zhou M, Ball JM, Schroeder F. Role of sterol carrier protein-2 N-terminal membrane binding domain in sterol transfer. Biochemistry 41: 12149-12162, 2002.
42. Huang WY, Aramburu J, Douglas PS, Izumo S. Transgenic expression of green fluorescence protein can cause dilated cardiomyopathy. Nat Med 6: 582-583, 2000. (Pubitemid 30305874)
43. Incerpi S, Jefferson JR, Wood WG, Ball WJ, Schroeder F. Na pump and plasma membrane structure in L-cell fibroblasts expressing rat liver fatty acid binding protein. Arch Biochem Biophys 298: 35-42, 1992.
44. Jefferson JR, Slotte JP, Nemecz G, Pastuszyn A, Scallen TJ, Schroeder F. Intracellular sterol distribution in transfected mouse L-cell fibroblasts expressing rat liver fatty acid binding protein. J Biol Chem 266: 5486-5496, 1991.
45. Kamijo-Ikemori A, Sugaya T, Sekizuka A, Hirata K, Kimura K. Amelioration of diabetic tubulointerstitial damage in liver type fatty acid binding protein transgenic mice. Nephrol Dial Transplant 24: 788-800, 2009.
46. Kawata S, Imai Y, Inada M, Inui M, Kakimoto H, Fukuda K, Maeda Y, Tarui S. Modulation of cholesterol 7-α hydroxylase activity by nsLTP in human liver - possibly altered regulation of its cytosolic level in patients with gallstones. Clin Chim Acta 197: 201-208, 1991.
47. Lamhonwah AM, Tein I. GFP-human high-affinity carnitine transporter OCTN2 protein: subcellular localization and functional restoration of carnitine uptake in mutant cell lines with carnitine transporter defect. Biochem Biophys Res Commun 264: 909-914, 1999.
48. Liu HS, Jan MS, Chou CK, Chen PH, Ke NJ. Is the green fluorescent protein toxic to the living cells? Biochem Biophys Res Commun 260: 712-717, 1999. (Pubitemid 29371116)
49. Lopez JM, Bennett MK, Sanchez HB, Rosenfeld JM, Osborne TF. Sterol regulation of acetyl CoA carboxylase: a mechanism for coordinate control of cellular lipid. Proc Natl Acad Sci USA 93: 1049-1053, 1996.
50. Magnusson AL, Waterman IJ, Jansson T, Powell TL. Triglyceride hydrolase activities and expression of fatty acid binding proteins in the human placenta in pregnancies complicated by intrauterine growth restriction and diabetes. J Clin Endocrinol Metab 89: 4607-4614, 2004.
51. Martin GG, Atshaves BP, McIntosh AL, Mackie JT, Kier AB, Schroeder F. Liver fatty acid binding protein (L-FABP) gene ablation alters liver bile acid metabolism in male mice. Biochem J 391: 549-560, 2005. (Pubitemid 41634780)
52. Martin GG, Atshaves BP, McIntosh AL, Mackie JT, Kier AB, Schroeder F. Liver fatty acid binding protein (L-FABP) gene ablation potentiates hepatic cholesterol accumulation in cholesterol-fed female mice. Am J Physiol Gastrointest Liver Physiol 290: G36-G48, 2006.
53. Martin GG, Atshaves BP, McIntosh AL, Mackie JT, Kier AB, Schroeder F. Liver fatty acid binding protein gene-ablated female mice exhibit increased age-dependent obesity. J Nutr 138: 1859-1865, 2008.
54. Martin GG, Atshaves BP, McIntosh AL, Mackie JT, Kier AB, Schroeder F. Liver fatty acid binding protein gene ablation enhances age-dependent weight gain in male mice. Mol Cell Biochem 324: 101-115, 2009.
55. Martin GG, Danneberg H, Kumar LS, Atshaves BP, Erol E, Bader M, Schroeder F, Binas B. Decreased liver fatty acid binding capacity and altered liver lipid distribution in mice lacking the liver fatty acid binding protein (L-FABP) gene. J Biol Chem 278: 21429-21438, 2003. (Pubitemid 36792539)
56. Martin GG, Hostetler HA, McIntosh AL, Tichy SE, Williams BJ, Russell DH, Berg JM, Spencer TA, Ball JA, Kier AB, Schroeder F. Structure and function of the sterol carrier protein-2 (SCP-2) N-terminal pre-sequence. Biochemistry 47: 5915-5934, 2008. (Pubitemid 351770022)
57. Martin GG, Huang H, Atshaves BP, Binas B, Schroeder F. Ablation of the liver fatty acid binding protein gene decreases fatty acyl CoA binding capacity and alters fatty acyl CoA pool distribution in mouse liver. Biochemistry 42: 11520-11532, 2003. (Pubitemid 37205747)
58. Martinez-Botas J, Anderson JB, Tessier D, Lapillonne A, Chang BHJ, Quast MJ, Gorenstein D, Chen KH, Chan L. Absence of perilipin results in leanness and reverses obesity in Leprdb/db mice. Nat Genet 26: 474-479, 2000.
59. Matarese V, Stone RL, Waggoner DW, Bernlohr DA. Intracellular fatty acid trafficking and the role of cytosolic lipid binding proteins. Prog Lipid Res 28: 245-272, 1989.
60. McArthur MJ, Atshaves BP, Frolov A, Foxworth WD, Kier AB, Schroeder F. Cellular uptake and intracellular trafficking of long chain fatty acids. J Lipid Res 40: 1371-1383, 1999.
61. McIntosh AL, Atshaves BP, Hostetler HA, Huang H, Davis J, Lyuksyutova OI, Landrock D, Kier AB, Schroeder F. Liver type fatty acid binding protein (L-FABP) gene ablation reduces nuclear ligand distribution and peroxisome proliferator activated receptor-alpha activity in cultured primary hepatocytes. Arch Biochem Biophys 485: 160-173, 2009.
62. Morrow FD, Allen CE, Martin RJ. Intracellular fatty acid-binding protein: hepatic levels in lean and obese rats. Fed Proc 38: 280, 1979.
63. Munoz V, Serrano L. Elucidating the folding problem of helical peptides using empirical parameters. Nat Struct Mol Biol 1: 399-409, 1994. (Pubitemid 2083893)
64. Murphy EJ. L-FABP and I-FABP expression increase NBD-stearate uptake and cytoplasmic diffusion in L-cells. Am J Physiol Gastrointest Liver Physiol 275: G244-G249, 1998.
65. Murphy EJ, Prows DR, Jefferson JR, Schroeder F. Liver fatty acid binding protein expression in transfected fibroblasts stimulates fatty acid uptake and metabolism. Biochim Biophys Acta 1301: 191-198, 1996.
66. Nemecz G, Schroeder F. Selective binding of cholesterol by recombinant fatty acid-binding proteins. J Biol Chem 266: 17180-17186, 1991. (Pubitemid 21907922)
67. Newberry EP, Kennedy SM, Xie Y, Luo J, Davidson NO. Diet-induced alterations in intestinal and extrahepatic lipid metabolism in liver fatty acid binding protein knockout mice. Mol Cell Biochem 326: 79-86, 2009.
68. Newberry EP, Kennedy SM, Xie Y, Luo J, Stanley SE, Semenkovich CF, Crooke RM, Graham MJ, Davidson NO. Altered hepatic triglyceride content after partial hepatectomy without impaired liver regeneration in multiple murine genetic models. Hepatology 48: 1097-1105, 2008.
69. -/- mice is abrogated with SF, but not PUFA, feeding and attenuated after cholesterol supplementation. Am J Physiol Gastrointest Liver Physiol 294: G307-G314, 2008.
70. Newberry EP, Xie Y, Kennedy S, Buhman KK, Luo J, Gross RW, Davidson NO. Decreased hepatic triglyceride accumulation and altered fatty acid uptake in mice with deletion of the liver fatty acid binding protein gene. J Biol Chem 278: 51664-51672, 2003.
71. Newberry EP, Xie Y, Kennedy SM, Luo J, Davidson NO. Protection against Western diet-induced obesity and hepatic steatosis in liver fatty acid binding protein knockout mice. Hepatology 44: 1191-1205, 2006.
72. Norris AW, Spector AA. Very long chain n-3 and n-6 polyunsaturated fatty acids bind strongly to liver fatty acid binding protein. J Lipid Res 43: 646-653, 2002.
73. Ostenson CG, Ahren B, Karlsson S, Knudsen J, Efendic S. Inhibition by rat diazepam-binding inhibitor/acyl-CoA-binding protein of glucose-induced insulin secretion in the rat. Eur J Endocrinol 131: 201-204, 1994. (Pubitemid 24265355)
74. Papadopoulos V, Brown AS. Role of the peripheral-type benzodiazepine receptor and the polypeptide diazepam binding inhibitor in steroidogenesis. J Steroid Biochem Mol Biol 53: 103-110, 1995.
75. Parr RD, Martin GG, Hostetler HA, Schroeder ME, Mir KD, Kier AB, Ball JM, Schroeder F. A new N-terminal recognition domain in caveolin-1 interacts with sterol carrier protein-2 (SCP-2). Biochemistry 46: 8301-8314, 2007.
76. Petrescu AD, Payne HR, Boedeker AL, Chao H, Hertz R, Bar-Tana J, Schroeder F, Kier AB. Physical and functional interaction of acyl CoA binding protein (ACBP) with hepatocyte nuclear factor-4alpha (HNF4alpha). J Biol Chem 278: 51813-51824, 2003.
77. Prows DR, Murphy EJ, Schroeder F. Intestinal and liver fatty acid binding proteins differentially affect fatty acid uptake and esterification in L-Cells. Lipids 30: 907-910, 1995.
78. Puglielli L, Rigotti A, Amigo L, Nunez L, Greco AV, Santos MJ, Nervi F. Modulation on intrahepatic cholesterol trafficking: Evidence by in vivo antisense treatment for the involvement of sterol carrier protein-2 in newly synthesized cholesterol transfer into bile. Biochem J 317: 681-687, 1996.
79. Reddy DS, Kulkarni SK. The role of GABA-A and mitochondrial diazepam-binding inhibitor receptors on the effects of neurosteroids on food intake in mice. Psychopharmacology (Berl) 137: 391-400, 1998.
80. Ren S, Hylemon P, Marques D, Hall E, Redford K, Gil G, Pandak WM. Effect of increasing the expression of cholesterol transporters (StAR, MLN64, and SCP-2) on bile acid synthesis. J Lipid Res 45: 2123-2131, 2004.
81. Reymond MT, Huo S, Duggan B, Wright PE, Dyson HJ. Contribution of increased length and intact capping sequences to the conformational preference for helix in a 31-residue peptide from the C terminus of myohemerythrin. Biochemistry 17: 5234-5244, 1997.
82. Richieri GV, Ogata RT, Kleinfeld AM. Equilibrium constants for the binding of fatty acids with fatty acid binding proteins from adipocyte, intestine, heart, and liver measured with the fluorescent probe ADIFAB. J Biol Chem 269: 23918-23930, 1994.
83. Richieri GV, Ogata RT, Zimmerman AW, Veerkamp JH, Kleinfeld AM. Fatty acid binding proteins from different tissues show distinct patterns of fatty acid interaction. Biochemistry 39: 7197-7204, 2000.
84. Robitaille J, Brouillette C, Lemieux S, Perusse L, Gaudet D, Vohl MC. Plasma concentrations of apolipoprotein B are modulated by a gene-diet interaction effect between the L-FABP T94A polymorphism and dietary fat intake in French-Canadian men. Mol Genet Metab 82: 296-303, 2004. (Pubitemid 39078709)
85. Sams GH, Hargis BM, Hargis PS. Identification of two lipid binding proteins from liver of Gallus domesticus. Comp Biochem Physiol 99B: 213-219, 1991.
86. Schoer J, Gallegos A, Starodub O, Petrescu A, Roths JB, Kier AB, Schroeder F. Lysosomal membrane cholesterol dynamics: role of sterol carrier protein-2 gene products. Biochemistry 39: 7662-7677, 2000.
87. Schroeder F, Atshaves BP, Gallegos AM, McIntosh AL, Liu JC, Kier AB, Huang H, Ball JM. Lipid rafts and caveolae organization. In: Advances in Molecular and Cell Biology, edited by Frank PG and Lisanti MP. Amsterdam: Elsevier, 2005, p. 3-36.
88. Schroeder F, Butko P, Nemecz G, Jefferson JR, Powell D, Rymaszewski Z, Dempsey ME, Kukowska-Latallo J, Lowe JB. Sterol carrier protein: a ubiquitous protein in search of a function. In: Bioengineered Molecules: Basic and Clinical Aspects, edited by Verna R, Blumenthal R, and Frati L. New York: Raven, 1989, p. 29-45.
89. Schroeder F, Dempsey ME, Fischer RT. Sterol and squalene carrier protein interactions with fluorescent delta 5,7,9(11)-cholestatrien-3 beta-ol. J Biol Chem 260: 2904-2911, 1985. (Pubitemid 15141438)
90. Schroeder F, Frolov A, Schoer J, Gallegos A, Atshaves BP, Stolowich NJ, Scott AI, Kier AB. Intracellular sterol binding proteins, cholesterol transport and membrane domains. In: Intracellular Cholesterol Trafficking, edited by Chang TY and Freeman DA. Boston: Kluwer Academic, 1998, p. 213-234.
91. Schroeder F, Frolov A, Starodub O, Russell W, Atshaves BP, Petrescu AD, Huang H, Gallegos A, McIntosh A, Tahotna D, Russell D, Billheimer JT, Baum CL, Kier AB. Pro-sterol carrier protein-2: role of the N-terminal presequence in structure, function, and peroxisomal targeting. J Biol Chem 275: 25547-25555, 2000. (Pubitemid 30687058)
92. Schroeder F, Jefferson JR, Kier AB, Knittell J, Scallen TJ, Wood WG, Hapala I. Membrane cholesterol dynamics: cholesterol domains and kinetic pools. Proc Soc Exp Biol Med 196: 235-252, 1991.
93. Schroeder F, Petrescu AD, Huang H, Atshaves BP, McIntosh AL, Martin GG, Hostetler HA, Vespa A, Landrock K, Landrock D, Payne HR, Kier AB. Role of fatty acid binding proteins and long chain fatty acids in modulating nuclear receptors and gene transcription. Lipids 43: 1-17, 2008. (Pubitemid 351206956)
94. Schwarz M, Russell DW, Dietschy JM, Turley SD. Alternate pathways of bile acid synthesis in the cholesterol 7 alpha hydroxylase knockout mouse are not upregulated by either cholesterol or cholestyramine feeding. J Lipid Res 42: 1594-1603, 2001. (Pubitemid 33020091)
95. Seedorf U, Raabe M, Ellinghaus P, Kannenberg F, Fobker M, Engel T, Denis S, Wouters F, Wirtz KWA, Wanders RJA, Maeda N, Assmann G. Defective peroxisomal catabolism of branched fatty acyl coenzyme A in mice lacking the sterol carrier protein-2/sterol carrier protein-x gene function. Genes Dev 12: 1189-1201, 1998.
96. 13C-NMR investigation of cholesterol and fatty acid binding sites. J Biol Chem 274: 35425-35433, 1999.
97. Storch J, Corsico B. The emerging functions and mechanisms of mammalian fatty acid-binding proteins. Annu Rev Nutr 28: 73-95, 2008.
98. Tansey JT, Sztalryd C, Gruia-Gray J, Roush DL, Zee JV, Gavrilova O, Reitman ML, Deng CX, Li C, Kimmel AR, Londos C. Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity. Proc Natl Acad Sci USA 98: 6494-6499, 2001. (Pubitemid 32488265)
99. Thompson J, Ory J, Reese-Wagoner A, Banaszak L. The liver fatty acid binding protein-comparison of cavity properties of intracellular lipid binding proteins. Mol Cell Biochem 192: 9-16, 1999.
100. Turley SD, Schwarz M, Spady DK, Dietschy JM. Gender related differences in bile acid and sterol metabolism in outbred CD-1 mice fed low and high cholesterol diets. Hepatology 28: 1088-1094, 1998.
101. Woodford JK, Behnke WD, Schroeder F. Liver fatty acid binding protein enhances sterol transfer by membrane interaction. Mol Cell Biochem 152: 51-62, 1995.
102. Xie Y, Newberry EP, Kennedy SM, Luo J, Davidson NO. Increased susceptibility to diet-induced gallstones in liver fatty acid binding protein knockout mice. J Lipid Res 50: 977-987, 2009.
103. Zanlungo S, Amigo L, Mendoza H, Glick J, Rodriguez A, Kozarsky K, Miquel JF, Rigotti A, Nervi F. Overexpression of sterol carrier protein-2 in mice leads to increased hepatic cholesterol content and enterohepatic circulation of bile acids (Meeting Abstract). Gastroenterology 118: A997, 2000.
104. Zhou M, Parr RD, Petrescu AD, Payne HR, Atshaves BP, Kier AB, Ball JA, Schroeder F. Sterol carrier protein-2 directly interacts with caveolin-1 in vitro and in vivo. Biochemistry 43: 7288-7306, 2004. (Pubitemid 38750178)